NCT00595140 arm group eccbc87e4b5ce2fe28308fd9f2a7baf3 [clinicaltrials_resource:NCT00595140/arm-group/eccbc87e4b5ce2fe28308fd9f2a7baf3]
NCT00595140 arm group eccbc87e4b5ce2fe28308fd9f2a7baf3 [clinicaltrials_resource:NCT00595140/arm-group/eccbc87e4b5ce2fe28308fd9f2a7baf3]
Bio2RDF identifier
NCT00595140/arm-group/eccbc87e4b5ce2fe28308fd9f2a7baf3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... cbc87e4b5ce2fe28308fd9f2a7baf3
description [clinicaltrials_vocabulary:description]
Patients with acromegaly on st ...... on of cabergoline 0.5mg orally
identifier
clinicaltrials_resource:NCT00595140/arm-group/eccbc87e4b5ce2fe28308fd9f2a7baf3
title
NCT00595140 arm group eccbc87e4b5ce2fe28308fd9f2a7baf3
@en
type
label
NCT00595140 arm group eccbc87e ...... bc87e4b5ce2fe28308fd9f2a7baf3]
@en